Cargando…
Tolerability of neoadjuvant chemotherapy for esophageal cancer in elderly patients over 76 years of age
Although the Japan Clinical Oncology Group trial demonstrated that neoadjuvant chemotherapy (NAC) with 5-fluorouracil plus cis-diamminedichloroplatinum had significant survival benefits, it excluded elderly patients aged ≥ 76 years. Therefore, our study aimed to evaluate the tolerability of NAC in e...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nagoya University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350567/ https://www.ncbi.nlm.nih.gov/pubmed/35967940 http://dx.doi.org/10.18999/nagjms.84.2.388 |